Dominant-negative inhibition of the receptor tyrosine kinase receptor AXL 
suppresses glioma cell migration and invasion and prolongs survival

Vajkoczy, P.; Kunkel, A.; Erber, R.; Capelle, H.; Eichelsbacher, U.; Ullrich, A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Dominant-negative inhibition of the receptor tyrosine kinase receptor AXL suppresses glioma cell migration and invasion and prolongs survival

MPS-Authors

/persons/resource/persons77929

Eichelsbacher, U.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78812

Ullrich, A.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Vajkoczy, P., Kunkel, A., Erber, R., Capelle, H., Eichelsbacher, U., & Ullrich, A. (2005). Dominant-negative inhibition of the receptor tyrosine kinase receptor AXL suppresses glioma cell migration and invasion and prolongs survival. Neuro-Oncology, 7(3), 354-354.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-65E1-9

Abstract

There is no abstract available